Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients-Reference-Cited by-同舟云学术

Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients

Published:2018-12-06 Issue:2 Volume:102 Page:111-122
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Ljung Rolf¹²,Auerswald Guenter³,Benson Gary⁴,Dolan Gerry⁵,Duffy Anne⁶,Hermans Cedric⁷,Jiménez‐Yuste Victor⁸,Lambert Thierry⁹,Morfini Massimo¹⁰,Zupančić‐Šalek Silva¹¹,Santagostino Elena¹²

Affiliation:

1. Department of Clinical Sciences—Paediatrics Lund University Lund Sweden

2. Malmö Centre for Thrombosis and Haemostasis Skåne University Hospital Malmö Sweden

3. Klinikum Bremen‐Mitte, Professor Hess Children’s Hospital Bremen Germany

4. Haemophilia and Thrombosis Centre Belfast City Hospital Belfast UK

5. Centre for Haemostasis and Thrombosis St Thomas’ Hospital London UK

6. WFH Psychosocial Committee, Irish Haemophilia Society Dublin Ireland

7. Haemostasis and Thrombosis Unit, Division of Haematology Cliniques Universitaires Saint‐Luc Brussels Belgium

8. Hospital Universitario La Paz, Autónoma University Madrid Spain

9. Hemophilia Care Center Faculté de Médecine Paris XI, Bicêtre AP‐HP Hospital Paris France

10. Italian Association of Haemophilia Centres Florence Italy

11. University Hospital Centre Zagreb School of Medicine University of Osijek and Medical School University of Zagreb Zagreb Croatia

12. Foundation IRCCS Cà Granda Maggiore Hospital Policlinico Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Milan Italy

Funder

Novo Nordisk

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13193

Reference88 articles.

1. World Federation of Hemophilia.WFH guidelines for the management of hemophilia.2014.http://www1.wfh.org/publications/files/pdf-1512.pdf. Accessed May 24 2016

2. International workshop on immune tolerance induction: consensus recommendations

3. Toward optimal therapy for inhibitors in hemophilia

4. European Study on Orthopaedic Status of haemophilia patients with inhibitors

5. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors;Thrombosis Research;2024-10

2. Activated factor X delivered by adeno-associated virus significantly inhibited bleeding and alleviated hemophilic synovitis in hemophilic mice;Gene Therapy;2024-09-10

3. The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art;Bleeding, Thrombosis and Vascular Biology;2024-09-04

4. Cost of hemophilia A in Brazil: a microcosting study;Health Economics Review;2024-08-06

5. Reduced Volume and Faster Infusion Rate of Activated Prothrombin Complex Concentrate: A Phase 3b/4 Trial in Adults with Hemophilia A with Inhibitors;TH Open;2024-07